4.7 Review

Multitasking bamboo leaf-derived compounds in prevention of infectious, inflammatory, atherosclerotic, metabolic, and neuropsychiatric diseases

期刊

PHARMACOLOGY & THERAPEUTICS
卷 235, 期 -, 页码 -

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2022.108159

关键词

Bamboo; Flavonoids; Anti-oxidative; Anti-inflammatory; Anti-apoptosis; Gut microbiota

资金

  1. Japan Society for the Promotion of Science KAKENHI [JP18K07457, JP16K19314]

向作者/读者索取更多资源

This review summarizes the potential prophylactic and therapeutic effects of bamboo leaf extract and its constituents against infectious, inflammatory, cardiovascular, metabolic, and neurological/neuropsychiatric diseases, including the mechanisms and effects of some constituent compounds, as well as the possible interaction with probiotics.
Bamboo is a medicinal plant, and has long been used as a traditional/folk medicine and a food preservative in Japan. Bamboo leaf contains many active ingredients with medicinal benefits. In particular, recent studies demonstrated that bamboo leaf extract and its constituents have great potential to prevent infectious, inflammatory, cardiovascular, metabolic, and neurological/neuropsychiatric diseases. In this review, we summarize the prophylactic and possible therapeutic effects of bamboo leaf extract and its constituent compounds against these disorders. The effects of the extract are explainable in part by the effects of some constituent compounds: p-coumaric acid, myricetin, orientin, stachyose, and vitexin. Moreover, coenzyme Q(10), an anti-oxidative constituent, alleviates oxidative stress which underlies the common pathogenic mechanisms of the development of diabetic complications, atherosclerosis and periodontal disease. Some flavonoids contained in bamboo leaf, such as orientin and vitexin, have been reported to regulate gut microbiota responsible for maintaining whole-body functions, suggesting a possible interaction between bamboo leaf extract and probiotics. Thus, bamboo leaf is a valuable natural resource for the development of multiple pharmacotherapies. (C) 2022 Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据